Ledyard National Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Ledyard National Bank’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-37	Closed	-$1K	–	744
2015 Q1	$1K	Hold	37	–	–	﹤0.01%	697
2014 Q4	$1K	Hold	37	–	–	﹤0.01%	718
2014 Q3	$1K	Hold	37	–	–	﹤0.01%	701
2014 Q2	$1K	Sell	37 -38	-51%	-$920	﹤0.01%	707
2014 Q1	$2K	Buy	+75	New	+$2K	﹤0.01%	685

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Ledyard National Bank's PTLA Position: Q2 2015 in Review

Ledyard National Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2015, closing a stake of 37 shares — an estimated $1K sold.

Ledyard National Bank first reported a position in PTLA in Q1 2014 and held it in 5 quarters. The position peaked at $2K in Q1 2014. 160 funds tracked by Wall St. Rank hold PTLA as of Q2 2015.

Ledyard National Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
Ledyard National Bank sold 37 Portola Pharmaceuticals, Inc. shares in Q2 2015, an estimated $1K.
Ledyard National Bank first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
Ledyard National Bank's Portola Pharmaceuticals, Inc. position peaked at $2K in Q1 2014.
160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2015.

Based on Ledyard National Bank's 13F filing for Q2 2015, filed 16 Jul 2015.